ArticleCancers2026

DNA Methyltransferase Inhibitors, Decitabine and Guadecitabine Overcome Immune-Checkpoint Blockade Resistance and Achieve Tumor Regression in the E0771 and 4T1 Murine Models of Triple-Negative Breast Cancer.

S Jennifer Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.